IPOBBTX
What to Watch as Bambusa Therapeutics Prices Its Nasdaq IPO
Bambusa Therapeutics Inc. (Nasdaq: BBTX) is expected to list on 2026-10-30, with pricing already set for the NASDAQ. The company has not disclosed a price range, but it sold 10,555,555 shares at $16.00 each for $168.9 million in gross proceeds. Bulls will focus on its long-acting bispecific pipeline in immunology and inflammation; bears will focus on clinical risk and a cash runway that the company says is not enough to fund 12 months of operations.
Oct 27, 20265 MIN